Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Kenyon

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 12, 2026
Hematology specialist nurse-led continuity-of-care for high-risk hematopoietic cell transplantation recipientsTing Wang, Li Wu, Aiyun Jin, et al.
Clinical Hematology International|November 20, 2024
Nurses' reported training needs for advanced cell therapies: a survey on behalf of the Nurses Group of the EBMTMichelle Kenyon, Sarah Jayne Liptrott, Annika Kisch, et al.
The Journal of Allergy and Clinical Immunology. Global|July 2, 2024
Patient-reported outcomes in HSCT for autoimmune diseases: Considerations on behalf of the EBMT ADWP, PAC, and Nurses GroupTobias Alexander, Noëlle Tassy, Ariadna Domenech, et al.
Environmental and Molecular Mutagenesis|June 5, 2021
Permitted daily exposure limits for noteworthy N-nitrosaminesGeorge E Johnson, Krista Dobo, Bhaskar Gollapudi, et al.
British Journal of Haematology|August 31, 2006
Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromesZi Yi Lim, Aloysius Y L Ho, Wendy Ingram, et al.
Bone Marrow Transplantation|July 5, 2023
The European Society for Blood and Marrow Transplantation (EBMT) roadmap and perspectives to improve nutritional care in patients undergoing hematopoietic stem cell transplantation on behalf of the Cellular Therapy and Immunobiology Working Party (CTIWP) and the Nurses Group (NG) of the EBMTAmanda Casirati, Isabel Salcedo, Emanuele Cereda, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2014
Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemiaJennifer Clay, Austin G Kulasekararaj, Victoria Potter, et al.
Archives of Dermatology|September 19, 2007
Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapyDaniel Creamer, Claire L Martyn-Simmons, Genevieve Osborne, et al.
Regulatory Toxicology and Pharmacology : RTP|April 16, 2021
Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA)Joel P Bercu, Melisa Masuda-Herrera, George Johnson, et al.
The Lancet. Haematology|September 29, 2022
Access to and affordability of CAR T-cell therapy in multiple myeloma: an EBMT position paperNico Gagelmann, Anna Sureda, Silvia Montoto, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 12, 2026
Hematology specialist nurse-led continuity-of-care for high-risk hematopoietic cell transplantation recipientsTing Wang, Li Wu, Aiyun Jin, et al.
Clinical Hematology International|November 20, 2024
Nurses' reported training needs for advanced cell therapies: a survey on behalf of the Nurses Group of the EBMTMichelle Kenyon, Sarah Jayne Liptrott, Annika Kisch, et al.
The Journal of Allergy and Clinical Immunology. Global|July 2, 2024
Patient-reported outcomes in HSCT for autoimmune diseases: Considerations on behalf of the EBMT ADWP, PAC, and Nurses GroupTobias Alexander, Noëlle Tassy, Ariadna Domenech, et al.
Environmental and Molecular Mutagenesis|June 5, 2021
Permitted daily exposure limits for noteworthy N-nitrosaminesGeorge E Johnson, Krista Dobo, Bhaskar Gollapudi, et al.
British Journal of Haematology|August 31, 2006
Outcomes of alemtuzumab-based reduced intensity conditioning stem cell transplantation using unrelated donors for myelodysplastic syndromesZi Yi Lim, Aloysius Y L Ho, Wendy Ingram, et al.
Bone Marrow Transplantation|July 5, 2023
The European Society for Blood and Marrow Transplantation (EBMT) roadmap and perspectives to improve nutritional care in patients undergoing hematopoietic stem cell transplantation on behalf of the Cellular Therapy and Immunobiology Working Party (CTIWP) and the Nurses Group (NG) of the EBMTAmanda Casirati, Isabel Salcedo, Emanuele Cereda, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2014
Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemiaJennifer Clay, Austin G Kulasekararaj, Victoria Potter, et al.
Archives of Dermatology|September 19, 2007
Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapyDaniel Creamer, Claire L Martyn-Simmons, Genevieve Osborne, et al.
Regulatory Toxicology and Pharmacology : RTP|April 16, 2021
Use of less-than-lifetime (LTL) durational limits for nitrosamines: Case study of N-Nitrosodiethylamine (NDEA)Joel P Bercu, Melisa Masuda-Herrera, George Johnson, et al.
The Lancet. Haematology|September 29, 2022
Access to and affordability of CAR T-cell therapy in multiple myeloma: an EBMT position paperNico Gagelmann, Anna Sureda, Silvia Montoto, et al.
Pageof 5